Rss Feed

Subscribe to Rss Feed feed
Latest Medical Research News and Research
Updated: 49 min 23 sec ago

Analysis highlights the differing physical side effects of antidepressants

Wed, 10/22/2025 - 12:33
Antidepressants can differ widely in how they physically affect the body, including around a 4 kg difference in weight change between certain drugs (approximately 2.5 kg weight loss from agomelatine and 2kg weight gain from maprotiline), confirms a systematic review and meta-analysis published in The Lancet.

Anaphylaxis antidote underprescribed for schoolchildren in England

Wed, 10/22/2025 - 12:30
Less than half of schoolchildren in England who are at risk of a serious and potentially life-threatening allergic reaction (anaphylaxis) to food were prescribed the antidote-an adrenaline [epinephrine] autoinjector, or AAI for short-finds an analysis of national prescribing data, published online in the Archives of Disease in Childhood.

Researchers gain new insights into aging based on studies in dogs

Wed, 10/22/2025 - 12:12
Lab-based studies have provided lots of information on the biology of aging, but it's unclear how lab discoveries apply to aging in the real world. Research in Aging Cell provides insights into aging based on studies in dogs.

Dreams happen beyond REM sleep, analysis shows

Wed, 10/22/2025 - 12:08
An international consortium of researchers has created the largest-ever database compiling records of brain activity during sleep and dream reports.

Researchers highlight ethical implications of clinical trial terminations

Wed, 10/22/2025 - 11:47
The termination of thousands of federal grants that fund clinical trials threatens to reverse substantial progress in understanding and treating the health challenges of marginalized populations, particularly children and adolescents who are already underrepresented in research.

Abstinence or limiting alcohol intake may lead to clinically meaningful blood pressure reductions

Wed, 10/22/2025 - 11:42
Light-to-moderate alcohol consumption is associated with increases in blood pressure (BP) and stopping drinking – even drinking less – may lead to clinically meaningful BP reductions, according to a study published today in JACC, the flagship journal of the American College of Cardiology.

People with multiple sclerosis found to have dysbiotic oral microbiome

Wed, 10/22/2025 - 11:37
With ads everywhere for pro- or pre-biotic foods and supplements, most people are familiar with the gut microbiome-the trillions of bacteria, fungi, and viruses that colonize our digestive tract-and the idea that keeping our gut microbiome healthy improves our overall health.

First-generation antihistamines increase delirium risk in older hospitalized patients

Wed, 10/22/2025 - 10:38
An analysis in the Journal of the American Geriatrics Society reveals that older inpatients admitted to physicians who prescribe higher amounts of first-generation antihistamines face an elevated risk of delirium while in the hospital.

Study reveals the negative behavioral and psychological consequences of fitness apps

Wed, 10/22/2025 - 10:34
A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media.

Novel method measures structure and function of the Achilles tendon in professional ballet dancers

Wed, 10/22/2025 - 10:30
A study in the Journal of Orthopaedic Research uses a noninvasive, nonradioactive imaging-based method to measure the structure and function of the Achilles tendon in professional ballet dancers.

Research reveals how signs of dyslexia can be detected in newborns' brains

Wed, 10/22/2025 - 10:25
Brain research can provide valuable information about children who may need extra support before they start struggling with reading in the classroom.

E2F2 protein identified as potential therapeutic target to prevent metabolic fatty liver disease progression

Wed, 10/22/2025 - 10:15
An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent metabolic fatty liver disease from progressing towards more serious conditions, such as cirrhosis or liver cancer.

New drug combination shows promise in treating colorectal cancer

Wed, 10/22/2025 - 10:01
Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from small lesions or polyps, its exact causes are unknown — only a few risk factors are known — and it is usually treated with surgery, chemotherapy and radiotherapy, or biological therapies.

CABI study sheds light on global trends in One Health research

Wed, 10/22/2025 - 09:57
A study published in the journal CABI One Health has revealed major inequalities in One Health research.

Study reveals minimum steps for longevity and heart health benefits in older women

Wed, 10/22/2025 - 09:53
Tracking daily steps has become a staple exercise metric as smart devices keep count with ease. This physical activity stimulates bodily repair and maintenance, which is especially important as we age.

Prescription drug advertising proves more effective in reducing smoking rates

Wed, 10/22/2025 - 09:46
A new peer-reviewed study in the INFORMS journal Marketing Science finds that direct-to-consumer (DTC) advertising for prescription smoking-cessation drugs meaningfully reduces cigarette use. At the same time, the research found that advertising for over the counter (OTC) nicotine products does not reduce cigarette use.

Rozanolixizumab prevents congenital heart block in high-risk pregnancy

Wed, 10/22/2025 - 09:19
Congenital heart block, sometimes referred to as cardiac neonatal lupus, is a rare but potentially life-threatening condition that affects babies born to mothers with specific autoantibodies - called anti-SSA/Ro antibodies - which can attack the fetal heart via its electrical conduction system, leading to a slower heart rate.

Study shows mRNA-based COVID vaccines enhance effectiveness of immune checkpoint therapy

Wed, 10/22/2025 - 08:07
Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center.

Proimmune expands into new 18,000 sq ft global headquarters enabling major expansion in immunology and life science innovation

Wed, 10/22/2025 - 08:00
ProImmune Ltd, a global leader in life science reagents and services, today announced the opening of its new global headquarters building at Oasis Park, Oxford, enabling significant expansion of its operations and capacity to serve its global client base.

Night shift work may raise risk of irritable bowel syndrome

Wed, 10/22/2025 - 03:33
The study indicates that night shift work increases irritable bowel syndrome risk, particularly among those with obesity, due to circadian rhythm disturbances.

Pages